Citigroup raised its 12-month price target for Northrop Grumman Corporation (NYSE: NOC) to $807 from $781, while maintaining a Buy rating, in a research note dated April 2, 2026. The revised target implies approximately 17% upside from the April 2, 2026 close of $690.50. The note reflects increased confidence in Northrop’s margin expansion trajectory as major programs transition from development to production phases.
Analyst Action: Citigroup’s Price Target Change and Rationale
Citigroup analyst John Godyn’s upward revision centers on three catalysts. First, the B-21 Raider stealth bomber entered low-rate initial production in Q1 2026, with full-rate production expected in 2027 — a transition that shifts program economics from investment-heavy development toward higher-margin sustainment revenue. Second, the Aeronautics and Space Systems segments are expected to drive operating margin expansion of 40–60 basis points annually through 2028, as capital expenditure requirements moderate. Third, Northrop’s backlog reached $88.4 billion at year-end 2025 — up 5% year-over-year — providing multi-year earnings visibility that underpins Citigroup’s above-consensus EPS estimates.
Citigroup’s valuation model applies approximately 22x forward earnings to its 2027 EPS estimate, a modest premium to the defense sector median of approximately 20x, reflecting Northrop’s differentiated exposure to classified space programs and next-generation nuclear deterrence. As of April 2, 2026, Northrop Grumman’s market capitalization stood at approximately $106.4 billion, according to Yahoo Finance.
Northrop Grumman Business Overview: Segments and Defense Revenue
Northrop Grumman operates through four segments: Aeronautics Systems, Defense Systems, Mission Systems, and Space Systems. For fiscal year 2025, the company reported total revenue of $38.6 billion, up 4.1% year-over-year, with operating margin of 11.8% — a 40 basis point improvement from FY2024.
The Space Systems segment delivered the strongest growth at 6.5%, driven by missile defense contracts and classified satellite work. Diluted EPS for FY2025 was $27.24, up from $25.37 in FY2024. Free cash flow was $3.2 billion, up 12% year-over-year as capital spending moderated. The Sentinel ground-based strategic deterrent program achieved critical design review in late 2025, with first deployment scheduled for 2028.
Defense Sector Context and Peer Comparison
U.S. defense spending continues to provide a supportive backdrop. The enacted FY2026 defense budget increased approximately 3.5% year-over-year, with priorities aligned to modernization, space resilience, and electronic warfare — core Northrop Grumman strengths. Global defense spending reached a record $2.72 trillion in 2024, marking the tenth consecutive year of growth.
Among the major defense primes as of April 2, 2026, Northrop’s revenue base is smaller than Lockheed Martin (NYSE: LMT) or RTX Corporation (NYSE: RTX), but its backlog as a percentage of annual revenue — approximately 229% — is among the highest in the sector, providing stronger multi-year visibility than most peers. Northrop’s FY2025 EPS growth of 7.4% and its 2026 estimated growth of approximately 14% outpace the sector median. Its 1.3% dividend yield lags larger peers, but its exposure to high-growth classified and space programs is viewed as a structural premium by analysts.
In March 2026, Northrop secured a U.S. Navy contract modification for up to nine additional SEWIP Block 3 electronic warfare systems valued at $1.1 billion, reinforcing its pipeline in Mission Systems.
Key Signals for Investors
Citigroup’s target of $807 assumes Northrop sustains 14% annual EPS growth through 2027 — execution on B-21 production ramp milestones in the next two quarters will be the most direct near-term test of that assumption.
The Sentinel program’s critical design review in late 2025 and planned 2028 deployment timeline remove a meaningful execution risk; investors should watch whether the program remains on schedule as a proxy for the Space Systems segment margin story.
Free cash flow of $3.2 billion in FY2025, growing 12% year-over-year, positions Northrop to sustain dividend increases and share repurchases even as R&D and program investments remain elevated.
Northrop’s backlog of $88.4 billion at year-end 2025 provides approximately 2.3 years of revenue coverage — a higher ratio than most peers — reducing near-term earnings risk if defense budget growth moderates.
The premium valuation of ~22x forward earnings leaves limited margin for error; investors should monitor congressional defense budget negotiations as the key macro catalyst that could either validate or compress that multiple.
The post Citigroup Raises Northrop Grumman Price Target as B-21 and Sentinel Programs Ramp first appeared on Alphastreet.
